Marker Therapeutics, Inc. (MRKR) › Capital ExpendituresMarker Therapeutics, Inc. (MRKR) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $02018: $147.7K2019: $375.0K$375.0K2017Capital Expenditures (USD)2019Fiscal YearCapital ExpendituresChange YoY2019$375.0K+153.9%2018$147.7K—2017$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share